Whiteoak Capital Pharma and Healthcare Fund - Regular Plan - Growth vs ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured
NAV, returns and costs — not a recommendation.
 Whiteoak Capital Pharma and Healthcare Fund - Regular Plan - Growth |  ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-Insured | |
|---|---|---|
| NAV | ₹16.823 | ₹43.43 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.79% | +7.31% |
| 3 year (p.a.) | +22.83% | +22.09% |
| 5 year (p.a.) | +22.83% | +15.97% |
| Expense ratio | 2.05% | 1.56% |
| Fund size | ₹664.02 Cr | ₹6,624.58 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.